Summary Terumo Corporation (Terumo) is a medical technology company. It manufactures and sells a wide range of medical care products including hospital and medical products, equipment and pharmaceuticals. Its major products include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusions systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company conducts its operations in three divisions, namely, General Hospital business, Cardiac and Vascular business, and Blood Management business. Terumo conducts its operations through subsidiaries and associate companies in Japan, Europe, Americas and Asia-Pacific. The company is headquartered in Tokyo, Japan. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Terumo Corporation - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 Terumo Corporation Company Snapshot 7 Terumo Corporation Company Overview 7 Terumo Corporation Pipeline Products and Clinical Trials Overview 8 Terumo Corporation - Pipeline Analysis Overview 10 Business Description 10 Key Facts 10 Terumo Corporation - Major Products and Services 11 Terumo Corporation Pipeline Products by Development Stage 13 Terumo Corporation Clinical Trials by Trial Status 15 Terumo Corporation Pipeline Products Overview 17 Bioresorbable Coronary Stent 17 Bioresorbable Coronary Stent Product Overview 17 CASPER Carotid Stent 18 CASPER Carotid Stent Product Overview 18 CMOS Image Glucose Sensor 19 CMOS Image Glucose Sensor Product Overview 19 Drug Coated Balloon Catheter 20 Drug Coated Balloon Catheter Product Overview 20 DuraHeart II 21 DuraHeart II Product Overview 21 ERIC Retrieval Device 22 ERIC Retrieval Device Product Overview 22 FRED Flow-Diverting Stent 23 FRED Flow-Diverting Stent Product Overview 23 FRED Flow-Diverting Stent Clinical Trial 24 Iberis Renal Sympathetic Denervation System 25 Iberis Renal Sympathetic Denervation System Product Overview 25 Iberis Renal Sympathetic Denervation System Clinical Trial 26 Liver Cancer Ablation System 27 Liver Cancer Ablation System Product Overview 27 Mirasol Pathogen Reduction Technology System - Platelets 28 Mirasol Pathogen Reduction Technology System - Platelets Product Overview 28 Mirasol Pathogen Reduction Technology System - Platelets Clinical Trial 29 Mirasol Pathogen Reduction Technology System - Whole Blood 30 Mirasol Pathogen Reduction Technology System - Whole Blood Product Overview 30 Mirasol Pathogen Reduction Technology System - Whole Blood Clinical Trial 31 Needleless Infusion System 32 Needleless Infusion System Product Overview 32 PTA Balloon Catheter - Above Knee 33 PTA Balloon Catheter - Above Knee Product Overview 33 Terufusion 34 Terufusion Product Overview 34 Therapeutic Apheresis System 35 Therapeutic Apheresis System Product Overview 35 VFC /Hydrofill Coil 36 VFC /Hydrofill Coil Product Overview 36 Wrist Artery Guidewire 37 Wrist Artery Guidewire Product Overview 37 Terumo Corporation - Key Competitors 38 Terumo Corporation - Key Employees 39 Terumo Corporation - Locations And Subsidiaries 42 Head Office 42 Other Locations & Subsidiaries 42 Recent Developments 46 Terumo Corporation, Recent Developments 46 Mar 02, 2016: NICE recommends new sickle cell treatment device that could save the NHS millions 46 Feb 11, 2016: Terumo Cardiovascular Group Introduces the CAPIOX FX Advance Oxygenator 47 Dec 15, 2015: Olympus to Distribute Terumo GLIDEWIRE, Endoscopic Hydrophilic Coated Guidewire for Gastroenterological Endoscopy 47 Nov 10, 2015: Baskent University Hospital Publish a Retrospective Study on Their Experience With Therapeutic Plasma Exchange and Other Treatment Options in Patients With Guillain- Barre Syndrome 48 Oct 26, 2015: Terumo BCT Completes the First Clinical Study Reducing Malaria Transmission from Whole Blood Transfusions with Pathogen Reduction Technology 48 Oct 19, 2015: NICE plans to support new device to improve red blood cell exchange in sickle cell disease management 50 Oct 16, 2015: Terumo BCT Announces Implementation of Correct Connect System 50 Sep 18, 2015: Terumo Receives Approval for the Manufacturer and Sale of its HeartSheet Autologous Skeletal Myoblast Sheets in Japan 51 Sep 02, 2015: Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare 51 Aug 10, 2015: FDA Clears Seven-Day Platelet Storage and Wireless Capability for the Trima Accel System from Terumo 51 Appendix 53 Methodology 53 About GlobalData 53 Contact Us 53 Disclaimer 53
List of Tables
Terumo Corporation Pipeline Products and Clinical Trials Overview 8 Terumo Corporation Pipeline Products by Equipment Type 8 Terumo Corporation Pipeline Products by Indication 9 Terumo Corporation Clinical Trials by Trial Status 9 Terumo Corporation, Key Facts 10 Terumo Corporation, Major Products and Services 11 Terumo Corporation Number of Pipeline Products by Development Stage 13 Terumo Corporation Pipeline Products Summary by Development Stage 14 Terumo Corporation Clinical Trials by Trial Status 15 Terumo Corporation Clinical Trials Summary 16 Bioresorbable Coronary Stent - Product Status 17 Bioresorbable Coronary Stent - Product Description 17 CASPER Carotid Stent - Product Status 18 CASPER Carotid Stent - Product Description 18 CMOS Image Glucose Sensor - Product Status 19 CMOS Image Glucose Sensor - Product Description 19 Drug Coated Balloon Catheter - Product Status 20 Drug Coated Balloon Catheter - Product Description 20 DuraHeart II - Product Status 21 DuraHeart II - Product Description 21 ERIC Retrieval Device - Product Status 22 ERIC Retrieval Device - Product Description 22 FRED Flow-Diverting Stent - Product Status 23 FRED Flow-Diverting Stent - Product Description 23 FRED Flow-Diverting Stent - Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms 24 Iberis Renal Sympathetic Denervation System - Product Status 25 Iberis Renal Sympathetic Denervation System - Product Description 25 Iberis Renal Sympathetic Denervation System - Renal Sympathetic Denervation by Iberis System in Patients with Uncontrolled Hypertension - IBERIS - HTN Registry 26 Liver Cancer Ablation System - Product Status 27 Liver Cancer Ablation System - Product Description 27 Mirasol Pathogen Reduction Technology System - Platelets - Product Status 28 Mirasol Pathogen Reduction Technology System - Platelets - Product Description 28 Mirasol Pathogen Reduction Technology System - Platelets - Clinical Effectiveness of Standard Versus Pathogen-Reduced Buffy Coat-Derived Platelet Concentrates in Plasma in Hemato Oncological Patients 29 Mirasol Pathogen Reduction Technology System - Whole Blood - Product Status 30 Mirasol Pathogen Reduction Technology System - Whole Blood - Product Description 30 Mirasol Pathogen Reduction Technology System - Whole Blood - A Feasibility Study For Mirasol System in Patients with Red Blood Cells 31 Needleless Infusion System - Product Status 32 Needleless Infusion System - Product Description 32 PTA Balloon Catheter - Above Knee - Product Status 33 PTA Balloon Catheter - Above Knee - Product Description 33 Terufusion - Product Status 34 Terufusion - Product Description 34 Therapeutic Apheresis System - Product Status 35 Therapeutic Apheresis System - Product Description 35 VFC /Hydrofill Coil - Product Status 36 VFC /Hydrofill Coil - Product Description 36 Wrist Artery Guidewire - Product Status 37 Wrist Artery Guidewire - Product Description 37 Terumo Corporation, Key Employees 39 Terumo Corporation, Other Locations 42 Terumo Corporation, Subsidiaries 43
List of Figures
Terumo Corporation Pipeline Products by Equipment Type 9 Terumo Corporation Pipeline Products by Development Stage 13 Terumo Corporation Clinical Trials by Trial Status 15
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries sRead More...
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption ratRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.